Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.

被引：0

作者：

Boumelha, Jesse ^{[1
]}

de Carne, Sophie ^{[1
]}

Mugarza, Edurne ^{[1
]}

Romero-Clavijo, Pablo ^{[1
]}

Molina-Arcas, Miriam ^{[1
]}

Downward, Julian ^{[1
]}

机构：

[1] Francis Crick Inst, London, England

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1820

引用

页数：2

共 50 条

[11] MET inhibition radiosensitizes KRAS-mutant rectal cancer. [J].

D'Ambrosio, Antonio ;

Verginelli, Federica ;

Orzan, Francesca ;

Albano, Raffaella ;

Casanova, Elena ;

Luraghi, Paolo ;

De Bacco, Francesca ;

Bertotti, Andrea ;

Trusolino, Livio ;

Senetta, Rebecca ;

Sapino, Anna ;

Del Mastro, Elena ;

Gatti, Marco ;

Comoglio, Paolo M. ;

Boccaccio, Carla .

CANCER RESEARCH, 2021, 81 (13)

[12] Dissecting tumor cell heterogeneity to identify therapeutic vulnerabilities in Kras-mutant lung cancer. [J].

Padhye, Aparna ;

Rodriguez, B. Leticia ;

Fradette, Jared J. ;

Ungewiss, Christin ;

Gibbons, Don L. .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :55-55

[13] A combinatorial strategy for treating KRAS-mutant lung cancer [J].

Eusebio Manchado ;

Susann Weissmueller ;

John P. Morris ;

Chi-Chao Chen ;

Ramona Wullenkord ;

Amaia Lujambio ;

Elisa de Stanchina ;

John T. Poirier ;

Justin F. Gainor ;

Ryan B. Corcoran ;

Jeffrey A. Engelman ;

Charles M. Rudin ;

Neal Rosen ;

Scott W. Lowe .

Nature, 2016, 534 :647-651

[14] A combinatorial strategy for treating KRAS-mutant lung cancer [J].

Manchado, Eusebio ;

Weissmueller, Susann ;

Morris, John P. ;

Chen, Chi-Chao ;

Wullenkord, Ramona ;

Lujambio, Amaia ;

de Stanchina, Elisa ;

Poirier, John T. ;

Gainor, Justin F. ;

Corcoran, Ryan B. ;

Engelman, Jeffrey A. ;

Rudin, Charles M. ;

Rosen, Neal ;

Lowe, Scott W. .

NATURE, 2016, 534 (7609) :647-+

[15] Hope for targeted treatment of KRAS-mutant lung cancer [J].

Crisp, Alisa .

EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) :121-121

[16] cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma [J].

Giotopoulou, Georgia A. ;

Ntaliarda, Giannoula ;

Marazioti, Antonia ;

Lilis, Ioannis ;

Spiropoulou, Nikolitsa ;

Kalogianni, Foteini ;

Tourkochristou, Evanthia ;

Giopanou, Ioanna ;

Spella, Magda ;

Iliopoulou, Marianthi ;

Korfiati, Aigli ;

Theofilatos, Konstantinos ;

Mavroudi, Seferina ;

Mantamadiotis, Theofilos ;

Goldmann, Torsten ;

Marwitz, Sebastian ;

Stathopoulos, Georgios T. .

EUROPEAN RESPIRATORY JOURNAL, 2021, 58

[17] Treating KRAS-Mutant Lung Cancer With Combination Agents [J].

Shumeyko, Emma P. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (04) :315-315

[18] Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer. [J].

Arbour, Kathryn Cecilia ;

Ricciuti, Biagio ;

Rizvi, Hira ;

Hellmann, Matthew D. ;

Yu, Helena Alexandra ;

Ladanyi, Marc ;

Kris, Mark G. ;

Arcila, Maria E. ;

Rudin, Charles M. ;

Lito, Piro ;

Awad, Mark M. ;

Riely, Gregory J. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[19] Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer. [J].

Ozkan-Dagliyan, Irem ;

Goodwin, Craig M. ;

Bryant, Kirsten L. ;

George, Samuel D. ;

Lucas, Kelly ;

Gautam, Prson ;

Wennerberg, Krister ;

Cox, Adrienne D. ;

Der, Channing J. .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :68-68

[20] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS [J].

Xiufeng Pang ;

Mingyao Liu .

Chinese Journal of Cancer, 2016, 35 (11) :571-573

← 1 2 3 4 5 →